Brief: Trinity Biotech Reports Quarterly Total Revenues Of $18.5 Million
Nov 3 (Reuters) - Trinity Biotech Plc TRIB.O :
* TRINITY BIOTECH ANNOUNCES QUARTER 2 2022 FINANCIAL RESULTS
AND
PRELIMINARY Q3 2022 REVENUE GUIDANCE
* QTRLY TOTAL REVENUES $18.5 MILLION
* Q3 PRELIMINARY REVENUES TO BE WITHIN RANGE OF
APPROXIMATELY $19
MILLION TO $20 MILLION
* QTRLY LOSS PER ADS 28.6 CENTS
Source text for Eikon: ID:nGNX3bsR9g
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM